piracetam has been researched along with Cerebral Palsy in 7 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To monitor the effect of adding levetiracetam in paediatric patients with hemiplegic cerebral palsy and uncontrolled epilepsy." | 7.77 | Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy. ( Harbord, MG, 2011) |
| "To monitor the effect of adding levetiracetam in paediatric patients with hemiplegic cerebral palsy and uncontrolled epilepsy." | 3.77 | Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy. ( Harbord, MG, 2011) |
| "Levetiracetam is a commonly prescribed antiepileptic drug, and is generally well tolerated, but can eventually cause behavioral disturbances." | 1.38 | Levetiracetam-induced reversible autistic regression. ( Camacho, A; Espín, JC; Nuñez, N; Simón, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vles, GF | 1 |
| Hendriksen, JG | 1 |
| Visschers, A | 1 |
| Speth, L | 1 |
| Nicolai, J | 1 |
| Vles, JS | 1 |
| Mink, JW | 1 |
| Harbord, MG | 1 |
| Camacho, A | 1 |
| Espín, JC | 1 |
| Nuñez, N | 1 |
| Simón, R | 1 |
| Recio, MV | 1 |
| Hauser, RA | 1 |
| Louis, ED | 1 |
| Radhashakar, H | 1 |
| Sullivan, KL | 1 |
| Zesiewicz, TA | 1 |
| Vampirelli, P | 1 |
| Maritz, NG | 1 |
| Müller, FO | 1 |
| Pompe van Meerdervoort, HF | 1 |
1 trial available for piracetam and Cerebral Palsy
| Article | Year |
|---|---|
Piracetam in the management of spasticity in cerebral palsy.
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Evaluation Studies as | 1978 |
6 other studies available for piracetam and Cerebral Palsy
| Article | Year |
|---|---|
Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
Topics: Anticonvulsants; Athetosis; Cerebral Palsy; Child; Child, Preschool; Chorea; Female; Humans; Levetir | 2009 |
Is levetiracetam a treatment option for dyskinetic cerebral palsy?
Topics: Anticonvulsants; Cerebral Palsy; Child; Humans; Levetiracetam; Piracetam | 2009 |
Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
Topics: Adolescent; Anticonvulsants; Cerebral Palsy; Child; Child, Preschool; Drug Therapy, Combination; Epi | 2011 |
Levetiracetam-induced reversible autistic regression.
Topics: Anticonvulsants; Autistic Disorder; Cerebral Palsy; Child; Cognition Disorders; Epilepsy; Female; Hu | 2012 |
Chorea in a patient with cerebral palsy: treatment with levetiracetam.
Topics: Adult; Anticonvulsants; Cerebral Palsy; Chorea; Female; Humans; Levetiracetam; Piracetam; Treatment | 2005 |
[Piracetam in child neuropsychiatry. Clinical experimentation in a child neuropsychiatry department].
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Down Syndrome; Drug Evaluation; Enuresis; Femal | 1978 |